Butterfly iQ

Learning Objectives

• Understand what makes Butterfly's ultrasound-on-a-chip different
• Understand how AI turns a low-cost probe into a guided imaging tool
• Evaluate the promise and limits of democratized point-of-care ultrasound

What Is Butterfly iQ?

Butterfly iQ is a handheld ultrasound probe made by Butterfly Network that replaces the traditional crystal-based transducer with a semiconductor chip. The result is a single, relatively low-cost probe that can image the whole body and plugs directly into a phone or tablet — where a conventional ultrasound cart is expensive and specialized, Butterfly aims to make imaging portable and affordable. The differentiator is what sits on top of the hardware: AI. The software provides guidance that helps less-experienced users position the probe and capture correct images, and automated interpretation for specific, well-defined tasks.

A concrete example landed in 2026: FDA clearance for a blind-sweep gestational-age capability, trained on tens of millions of images, that lets a minimally trained user estimate fetal age by sweeping the probe — a meaningful global-health tool where trained sonographers are scarce. With more than 150,000 devices deployed, Butterfly is a leader in democratizing point-of-care ultrasound. As a publicly traded company (on the New York Stock Exchange), its path depends on converting that large device footprint and its AI features into durable software and services revenue. The clinical caveats are the familiar ones: AI guidance and interpretation cover defined tasks, and a clinician remains responsible for the read.

Pricing

Butterfly sells the device plus software subscriptions, with individual, enterprise, and global-health arrangements. Exact pricing varies by market and plan.

Core Features

Whole-Body Handheld Imaging

A single chip-based probe images the whole body and connects to a phone or tablet, replacing far more expensive dedicated hardware.

AI Image Guidance

Software helps users position the probe and capture correct images, lowering the skill barrier that traditionally limited ultrasound to trained sonographers.

Automated Interpretation

For defined tasks — such as the FDA-cleared blind-sweep gestational-age estimation — the AI interprets the sweep and returns a result.

Portability and Access

Low cost and portability make point-of-care ultrasound feasible in clinics, ambulances, and low-resource settings where carts cannot go.

Strengths

• Ultrasound on a chip — one affordable, whole-body, portable probe
• AI lowers the skill barrier — guidance helps non-experts capture images
• FDA-cleared automated tasks — including blind-sweep gestational age
• Large deployed base — more than 150,000 devices
• Global-health reach — imaging where sonographers are scarce

Limitations and Considerations

• AI is task-specific — automated interpretation covers defined uses only
• Clinician responsibility — a qualified reader still interprets findings
• Image quality varies — depends on user technique despite guidance
• Commercial execution — as a listed company, adoption must become revenue
• Not a replacement for full systems — high-end imaging still needs dedicated machines

Best Use Cases

Key Takeaways

• Butterfly iQ is a handheld, chip-based, whole-body ultrasound probe that plugs into a phone or tablet
• AI guidance helps less-experienced users capture correct images, and automated interpretation handles defined tasks
• A 2026 FDA clearance for blind-sweep gestational-age estimation is a notable global-health capability
• With 150,000-plus devices deployed, Butterfly is a leader in democratizing point-of-care ultrasound; as a public company, adoption must convert to revenue
• AI features are task-specific and a clinician remains responsible for interpreting findings